本文選題：益氣活血化痰方　切入點(diǎn)：阿托伐他汀　出處：《重慶醫(yī)學(xué)》2017年28期

【摘要】：目的探討益氣活血化痰方聯(lián)合小劑量阿托伐他汀對(duì)高危性慢性阻塞性肺疾病(COPD)患者動(dòng)脈僵硬度、血液黏度及預(yù)后的影響。方法隨機(jī)數(shù)字表法將240例存在心血管病變危險(xiǎn)因素的高危性COPD患者分成他汀組(A組)、益氣活血化痰組(B組)、聯(lián)合組(C組)和對(duì)照組(D組),每組60例。4組均予以常規(guī)治療方案,A組聯(lián)合小劑量阿托伐他汀,B組聯(lián)合益氣活血化痰方,C組在A組基礎(chǔ)上聯(lián)合益氣活血化痰方,均持續(xù)治療6個(gè)月。觀察4組治療前后中醫(yī)證候積分、動(dòng)脈僵硬度指標(biāo)及血液流變學(xué)指標(biāo)變化差異,記錄其不良反應(yīng)發(fā)生情況及預(yù)后情況。結(jié)果治療6個(gè)月后,4組患者中醫(yī)證候積分及頸動(dòng)脈-股動(dòng)脈脈搏波傳導(dǎo)速度(PWV)水平均較治療前明顯降低,且C組、A組、B組、D組逐漸升高(P0.05)。治療6個(gè)月后,除D組患者全血黏度、紅細(xì)胞壓積未見(jiàn)明顯改變(P0.05),其余3組患者均較治療前明顯降低,C組明顯低于A組和B組(P0.05),A組和B組比較差異無(wú)統(tǒng)計(jì)學(xué)意義(P0.05)。4組患者不良反應(yīng)發(fā)生率比較差異無(wú)統(tǒng)計(jì)學(xué)意義(P0.05),C組、A組、B組、D組患者BODE指數(shù)逐漸升高(P0.05)。結(jié)論益氣活血化痰方聯(lián)合小劑量阿托伐他汀對(duì)調(diào)節(jié)有心血管病變危險(xiǎn)因素的高危性COPD患者血液流變學(xué)狀態(tài)、促進(jìn)患者預(yù)后恢復(fù)等具有積極作用。
[Abstract]:Objective to investigate the Yiqi Huoxue Huatan Decoction Combined with small dose of atorvastatin on high risk of chronic obstructive pulmonary disease (COPD) patients with arterial stiffness, affecting blood viscosity and prognosis. Methods randomly 240 cases of cardiovascular disease and risk factors of high-risk COPD patients were divided into atorvastatin group (A group), Guanxinping group (B group), combination group (C group) and control group (D group), each group of 60 cases of.4 group were given conventional treatment, A group combined with low-dose atorvastatin, B group combined with Yiqi Huoxue Huatan recipe group, C in A were based on the combination of vital qi blood phlegm, continued 6 months of treatment. The 4 groups were observed before and after treatment of TCM syndrome integral, index difference of arterial stiffness index and blood rheology, record the occurrence of adverse reactions and prognosis. Results 6 months after treatment, 4 groups of patients with TCM syndrome score and carotid femoral pulse wave conduction Speed (PWV) levels were significantly lower than that before treatment, and C group, A group, B group, D group increased (P0.05). After 6 months of treatment, patients in D group blood viscosity, hematocrit did not change significantly (P0.05), the other 3 groups of patients were significantly lower than that before treatment, C group was significantly lower than that of A group and B group (P0.05), there was no significant difference between A group and B group (P0.05).4 groups of patients with adverse reaction rate had no significant difference (P0.05), C group, A group, B group, BODE index in patients with D group increased (P0.05). Conclusion Yiqi Huoxue Huatan recipe combined with small dose of atorvastatin with cardiovascular disease risk factors on the regulation of high-risk COPD patients blood rheology, promote the prognosis of recovery has a positive effect.

【作者單位】： 新疆醫(yī)科大學(xué)第一附屬醫(yī)院中醫(yī)內(nèi)科;
【分類號(hào)】：R563.9

【相似文獻(xiàn)】

相關(guān)期刊論文 前3條

1 溫朝陽(yáng);童一砂;李民;李玉柱;趙玉生;韓斌;李為民;謝立新;唐杰;;睡眠呼吸暫停低通氣綜合征對(duì)患者動(dòng)脈僵硬度的影響[J];南方醫(yī)科大學(xué)學(xué)報(bào);2010年12期

2 魏文軍;李學(xué)明;;益氣活血化痰方配合西藥治療肺纖維化30例[J];陜西中醫(yī);2009年08期

3 王霞;朱玲;;活血化痰益氣方治療慢性阻塞性肺疾病急性加重期患者59例[J];浙江中醫(yī)雜志;2014年05期

相關(guān)碩士學(xué)位論文 前1條

1 俞飛虹;動(dòng)脈僵硬度定量分析技術(shù)評(píng)價(jià)阻塞性睡眠呼吸暫停綜合征患者頸動(dòng)脈彈性功能[D];南京醫(yī)科大學(xué);2012年

，

本文編號(hào)：1729217